Skip to main content

Published locations for Line of therapy matters for assessing biologic’s serious infection risk in RA

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Line of therapy matters for assessing biologic’s serious infection risk in RA

User login

  • Reset your password
  • /content/line-therapy-matters-assessing-biologics-serious-infection-risk-ra
  • /familypracticenews/article/239298/rheumatoid-arthritis/line-therapy-matters-assessing-biologics
  • /fedprac/article/239298/rheumatoid-arthritis/line-therapy-matters-assessing-biologics-serious
  • /internalmedicinenews/article/239298/rheumatoid-arthritis/line-therapy-matters-assessing-biologics
  • /rheumatologynews/article/239298/rheumatoid-arthritis/line-therapy-matters-assessing-biologics
  • /rheumatology/article/239298/rheumatoid-arthritis/line-therapy-matters-assessing-biologics-serious
  • /internalmedicine/article/239298/rheumatoid-arthritis/line-therapy-matters-assessing-biologics
  • /familymedicine/article/239298/rheumatoid-arthritis/line-therapy-matters-assessing-biologics-serious